| Name | Ruplizumab |
|---|---|
| Synonyms | RUPLIZUMAB |
| Description | Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |